Precigen (PGEN) Return on Equity (2016 - 2025)

Precigen (PGEN) has disclosed Return on Equity for 13 consecutive years, with 97.02% as the latest value for Q3 2025.

  • On a quarterly basis, Return on Equity fell 9486.0% to 97.02% in Q3 2025 year-over-year; TTM through Sep 2025 was 97.02%, a 9486.0% decrease, with the full-year FY2022 number at 0.93%, up 71.0% from a year prior.
  • Return on Equity was 97.02% for Q3 2025 at Precigen, down from 4.9% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 4.9% in Q2 2025 to a low of 97.02% in Q3 2025.
  • A 5-year average of 6.37% and a median of 0.16% in 2021 define the central range for Return on Equity.
  • Biggest YoY gain for Return on Equity was 608bps in 2025; the steepest drop was -9486bps in 2025.
  • Precigen's Return on Equity stood at 0.05% in 2021, then skyrocketed by 1432bps to 0.8% in 2022, then crashed by -33bps to 0.54% in 2023, then tumbled by -596bps to 2.69% in 2024, then tumbled by -3508bps to 97.02% in 2025.
  • Per Business Quant, the three most recent readings for PGEN's Return on Equity are 97.02% (Q3 2025), 4.9% (Q2 2025), and 12.81% (Q1 2025).